KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Accounts Payables: 2009-2025

Historic Accounts Payables for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $22.6 million.

  • Neogenomics' Accounts Payables rose 36.92% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 36.92%. This contributed to the annual value of $21.6 million for FY2024, which is 6.26% up from last year.
  • Neogenomics' Accounts Payables amounted to $22.6 million in Q3 2025, which was down 17.75% from $27.5 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Accounts Payables registered a high of $28.5 million during Q3 2021, and its lowest value of $13.7 million during Q3 2022.
  • For the 3-year period, Neogenomics' Accounts Payables averaged around $19.8 million, with its median value being $18.3 million (2024).
  • Per our database at Business Quant, Neogenomics' Accounts Payables skyrocketed by 60.90% in 2021 and then crashed by 51.96% in 2022.
  • Quarterly analysis of 5 years shows Neogenomics' Accounts Payables stood at $17.9 million in 2021, then climbed by 14.45% to $20.5 million in 2022, then dropped by 0.86% to $20.3 million in 2023, then rose by 6.26% to $21.6 million in 2024, then surged by 36.92% to $22.6 million in 2025.
  • Its Accounts Payables stands at $22.6 million for Q3 2025, versus $27.5 million for Q2 2025 and $16.2 million for Q1 2025.